Amid a multi-year surge in vaccine misinformation sparked by the Covid-19 pandemic, social media posts claimed that the ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

Moderna MRNA is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat ...

Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad ...

The Senate has unanimously passed a measure that would implement labeling requirements for specific foods containing vaccines ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...

Sunshine Biopharma (SBFM) has completed additional studies on orthotopic human tumor models in mice confirming its K1.1 mRNA Lipid Nanoparticle product as a novel therapeutic agent for human ...

Southern RNA is an Australian CDMO specialising in producing nucleic acid products that support the clinical development of ...

Highlights of BioNTech’s oncology programs to be presented at AACR 2025: ...

Familiar vaccine misinformation resurfaces in a Facebook video, which claims that mRNA vaccines change people’s genes. There is no factual basis for this claim.